Therefore, the increase in P2X7 receptor levels in BV2 microglial cells and the hippocampus of mice injected with SARS-CoV-2 spike protein suggests that P2X7 might contribute to neuroinflammatory events related to COVID-19. Here, P2RX7 is linked to COVID-19.